NCT05492682 2025-09-05START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of CancerValo Therapeutics OyPhase 1 Active not recruiting15 enrolled
NCT06644755 2025-07-24First-in-Human Trial of DS-2243a in Participants With Advanced Solid TumorsDaiichi SankyoPhase 1 Recruiting150 enrolled
NCT04526509 2024-11-26Master Protocol to Assess Safety and Dose of First Time in Human Next Generation Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Advanced Solid TumorsAdaptimmunePhase 1 Terminated12 enrolled 12 charts
NCT05943990 2024-11-13Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell LiposarcomaAdaptimmunePhase 1 Terminated5 enrolled 16 charts
NCT06048705 2024-11-13Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung CancerAdaptimmunePhase 1 Terminated7 enrolled 19 charts
NCT03132922 2024-01-22MAGE-A4ᶜ¹º³²T for Multi-TumorAdaptimmunePhase 1 Active not recruiting71 enrolled
NCT03600649 2023-11-21Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related SarcomasSalarius Pharmaceuticals, LLCPhase 1 Unknown50 enrolled